FDA ad hotline
Executive Summary
As of Aug. 2, FDA received 2,016 calls or an average of 44 a week, FDA Medicine Staff Director Peter Rheinstein, MD, tells FDLI Sept. 14. The 800-number was set up in September 1991 primarily to handle complaints about promotions, but Rheinstein notes that "a relatively small percentage, just under 10%" of calls concern marketing and advertising. About 63% concern drug approval or usage questions and quite a number concern medication errors. Reviewing calls between May 4 and Aug. 2, FDA found 21% of calls came from pharmacists, 19% from physicians, 13% from consumers, 12% from nurses and 1% from veterinarians.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth